Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus dexmedetomidine anesthesia for bleeding control in endoscopic sinus surgery
IRCT20240916063055N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in paranasal sinus disease comparing Remifentanil arm with Dexmedetomidine arm (2 arms). Primary endpoints: Bleeding during surgery and Visual field during surgery. Started Nov 2024; status: completed.
02
Drugs
remifentanildexmedetomidine
03
Conditions
paranasal sinus disease
Beyond the preview
Go deeper on IRCT20240916063055N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240916063055N1.